Research ArticleArticle
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
Molecular Pharmacology April 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743
Te-Chun Hsia
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Chih-Yen Tu
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Yun-Ju Chen
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Ya-Ling Wei
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Meng-Chieh Yu
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Sheng-Chie Hsu
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Shing-Ling Tsai
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Wen-Shu Chen
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Ming-Hsin Yeh
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Chia-Jui Yen
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Yung-Luen Yu
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Tzung-Chi Huang
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Chih-Yang Huang
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Mien-Chie Hung
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
Wei-Chien Huang
Graduate Institutes of Integrated Medicine (T.-C.Hs.), Cancer Biology (M.-C.Y., S.-L.T., W.-S.C., Y.-L.Y., M.-C.H., W.-C.H.), and Basic Medical Science (C.-Y.H.), Departments of Internal Medicine (C.-Y.T.) and Biomedical Imaging and Radiological Science (T.-C.Hu.), and the Ph.D. Program for Cancer Biology and Drug Discovery (Y.-L.Y., W.-C.H.), China Medical University, Taichung, Taiwan; Department of Medical Research, E-DA Hospital, Kaohsiung, Taiwan (Y.-J.C.); Department of Biological Science and Technology, I-Shou University, Kaohsiung, Taiwan (Y.-J.C.); Center for Molecular Medicine (Y.-L.W., S.-C.H., Y.-L.Y., M.-C.H., W.-C.H.), Department of Internal Medicine (T.-C.Hs., C.-Y.T.), Division of Pulmonary and Critical Care Medicine (C.-Y.T.), Section of Breast Surgery (M.-H.Y.), China Medical University and Hospital, Taichung, Taiwan; Department of Life Science (C.-Y.T.), National Chung-Hsing University, Taichung, Taiwan; Internal Medicine, National Cheng-Kung University, Tainan, Taiwan (C.-J.Y.); Department of Biotechnology, Asia University, Taichung, Taiwan (Y.-L.Y., W.-C.H.); and Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.-C.H.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Lapatinib-Induced Metastasis in TNBCs
Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
Molecular Pharmacology April 1, 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743
Research ArticleArticle
Lapatinib-Induced Metastasis in TNBCs
Te-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, Ya-Ling Wei, Meng-Chieh Yu, Sheng-Chie Hsu, Shing-Ling Tsai, Wen-Shu Chen, Ming-Hsin Yeh, Chia-Jui Yen, Yung-Luen Yu, Tzung-Chi Huang, Chih-Yang Huang, Mien-Chie Hung and Wei-Chien Huang
Molecular Pharmacology April 1, 2013, 83 (4) 857-869; DOI: https://doi.org/10.1124/mol.112.082743
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement